References
- West D X, Liberta A E, Padhye S B, Chikate R C, Sonawane P B, Kumbhar A S. Yerande R G. Thiosemicarbazone complexes of copper(II): structural and biological studies. Coord. Chem. Rev. 1993, 123, 49–71. DOI:10.1016/0010-8545(93)85052-6.
- Reedijk J. Why does Cisplatin reach guanine-N7 with competing S-donor ligands available in the cell? Chem. Rev. 1999, 99, 2499–2510. doi: 10.1021/cr980422f
- Kamalakannan, P.; Venkappayya, D. Synthesis and characterization of cobalt and nickel chelates of 5-dimethylaminomethyl-2-thiouracil and their evaluation as antimicrobial and anticancer agents. J. Inorg. Biochem. 2002, 90, 22–37. doi: 10.1016/S0162-0134(02)00413-0
- Marzano, C.; Pellei M.; Colavito D.; Alidori, S.; Lobbia, G.G.; Gandin, V.; Tisato, F.; Santini C. Synthesis, characterization, and in vitro antitumor properties of Tris(hydroxymethyl)phosphine copper(I) complexes containing the new Bis(1,2,4-triazol-1-yl)acetate ligand. J. Med. Chem. 2006, 49, 7317–7324. DOI:10.1021/jm0601248.
- Cepeda, V.; Fuertes, M.A.; Castilla, J.; Alonso, C.; Quevedo, C.; Perez, J. M. Biochemical mechanisms of cisplatin cytotoxicity. Anti-Cancer Agents Med. Chem., 2007, 7, 3–18. doi: 10.2174/187152007779314044
- Kostova, I. Platinum complexes as anticancer agents. Recent Pat. Anticancer Drug Discov. 2006, 1, 1–22. doi: 10.2174/157489206775246458
- Clarke, M.J. Ruthenium in cancer chemotherapy. Platinum Met. Rev. 1988, 32, 198–199.
- Fruhauf, S.; Zeller, W. J. New platinum, titanium and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells. Cancer Research, 1991, 51, 2943–2948.
- Auzias, M., Therrien, B., Suss-Fink, G., Stepnicka, P., Han Ang, W., Dyson, P., J. Ferrocenyl pyridine arene Ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry and cytotoxicity. Inorg Chem, 2008, 47, 578–583. DOI:10.1021/ic7018742.
- Mahendiran D, Kumar R S, Rahiman A K. Heteroleptic silver(I) complexes with 2,2': 6',2"-terpyridines and naproxen: DNA interaction, EGFR/VEGFR2 kinase, growth inhibition and cell cycle arrest studies. Mater. Sci. Eng. C. 2017, 76, 601–615. DOI:10.1016/j.msec.2017.03.085.
- Rafi U M, Mahendiran D, Devi V G, Doble M, Rahiman A K. Pyridazine-based heteroleptic copper(II) complexes as potent anticancer drugs by inducing apoptosis and S-phase arrest in breast cancer cell. Inorganica Chim. Acta. 2018, 482, 160–169. DOI:10.1016/j.ica.2018.06.007.
- Menendez, E. Titanium complexes in cancer treatment. Crit. Rev. Oncol. Hemat. 2002, 42, 309–315. doi: 10.1016/S1040-8428(01)00224-4
- Connor, K.O.; Gill, C.; Tacke, M.; Rehmann, F.-J.K.; Strohfeldt, K.; Sweeney, N.; Fitzpatrick, J.M.; Watson, R.W.G. Novel titanocene anticancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells. Apoptosis. 2006, 11, 1205–1214. DOI:10.1007/s10495-006-6796-1.
- Pampillon, C.; Claffey, J.; Hogan, M.; Tacke, M. Novel achiral titanocene anticancer drugs synthesized from bis-N,N-dimethylamino fulvene and lithiated heterocyclic compounds. Bio-metals. 2008, 21, 197–204. DOI:10.1007/s10534-007-9108-5.
- Gao, L.M.; Melendez, E. Cytotoxic properties of titanocenyl amides on breast cancer cell line MCF-7. Met-Based Drugs, 2010, 2010, 1–6. DOI:10.1155/2010/286298.
- Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods, 1983, 65, 55–63. DOI:10.1016/0022-1759(83)90303-4.
- Kaushal, R.; Kumar, N.; Awasthi, P.; Nehra, K. Syntheses, characterization and antibacterial study of titanium complexes. Turk. J Chem, 2013, 37, 936–945. DOI:10.3906/kim-1302-36.
- Kaushal, R.; Kumar, N.; Chaudhary, A.; Arora, S.; Awasthi, P. Synthesis, spectral characterization, and antiproliferative studies of mixed ligand titanium complexes of adamantylamine. Bioinorganic chemistry and applications, 2014, 2014, 1–12. DOI:10.1155/2014/142828.
- Kumar, N., Kaushal, R., Chaudhary, A., Arora, S., Awasthi, P. Synthesis, structural elucidation, and in vitro antiproliferative activities of mixed-ligand titanium complexes. Med. Chem. Res. 2014, 23, 3897–3906. DOI:10.1007/s00044-014-0963-7.
- Kaushal R, Kumar N, Thakur A, Nehra K, Awasthi P, Kaushal R and Arora S. Synthesis, spectral characterization, antibacterial and anticancer activity of some titanium complexes. Anticancer Agents Med Chem. 18, 2018, 739–746. doi: 10.2174/1871520618666171219122431
- Sharma, H. K.; Kumar, R. Synthesis of organoheterobimetallic [Bu2Sn(IV)-Ti(IV)]-µ-oxoisopropoxide and its β-diketonates. Indian J Chem, 2008, 47A, 854–858.
- Gulcan, M.; Sonmez, M.; Berber, I. Synthesis, characterization and antimicrobial activity of a new pyrimidine schiff base and its Cu(II), Ni(II), Co(II), Pt(II), and Pd(II) complexes. Turk J Chem, 2012, 36, 189–200.
- Abdlseed, F.A.; El-ajaily M.M. Preparation and spectroscopic investigation of a schiff base metal complexes. Int J PharmTech Res, 2009, 1, 1097–1103.
- Czakis-Sulikowska, D.M.; Radwanska-Doczckalska, J.; Sojka, G. 4,4'-Dipyridyl complexes of rare-earth thiocyanates. Monatsh Chem, 1984, 115, 961–973. DOI:10.1007/BF00798764.
- Xiu-min, S.; Hai-yan, W.; Yan-bing, L.; Jing-xiu, Y.; Lei, C.; Ge, H.; Wei-qing, X.; Bing, Z. (2010) Spectroscopic Studies on Co(II), Ni(II), Zn(II) Complexes with 4,4′-Bipyridine. Chem Res Chinese Univ, 2010, 26, 1011–1015.
- Sharma, N.; Thakur, A.; Bhatt, S.S.; Chaudhary, S.C. Synthesis and characterization of di- and tri organotin(IV) complexes of 2-tert-butyl-4-methyl phenol. J Chem Sci, 2007, 119, 311–318. DOI:10.1007/s12039-007-0042-4.
- Dhanaraj, C. J; Nair, M. S. Synthesis and characterization of metal(II) complexes of poly(3-nitrobenzylidene-1-naphthylamine-co-succinic anhydride. Eur. Polym. J. 2009, 45, 565–572. DOI:10.1016/j.eurpolymj.2008.11.011.
- Ade S. B.; Deshpande M. N.; Kolhatkar, D. G. Synthesis, characterization and biological studies of 2-[1-(2-hydroxy-phenyl)-ethylidene amino]-4-methyl-phenol with Ti(IV) and Zr(IV) complexes. Int J Chem Tech Res, 2012, 4, 578–583.
- Penninger, J. M.; Kroemer, G. Mitochondria, AIF and caspases-rivaling for cell death execution. Nat Cell Biol, 2003, 5, 97–99. doi: 10.1038/ncb0203-97
- Ravagnan, L.; Roumier, T.; Kroemer G. Mitochondria, the killer organelles and their weapons. J Cell Physiol. 2002, 192, 131–137. doi: 10.1002/jcp.10111
- Christodoulou, C.V.; Eliopoulos, A.G.; Young, L.S.; Hodgkins, L.; Ferry, D.R.; Kerr, D.J. Antiproliferative activity and mechanism of action of titanocene dichloride. Brit J Cancer, 1988, 77, 2088–2097. DOI:10.1038/bjc.1998.352.